Clinical Trial Update: Mometasone Furoate Aqueous (MK-0887/SCH 032088) Nasal Spray vs Placebo and FLONASE® in Seasonal Allergic Rhinitis Patients (I94-001) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing mometasone furoate aqueous nasal spray to placebo and Flonase in seasonal allergic rhinitis; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Flonase (fluticasone propionate nasal spray)
• Mometasone furoate aqueous nasal spray (mometasone furoate aqueous nasal spray)

Snippet

Sponsor: Organon and Co | Conditions: Rhinitis, Allergic, Seasonal | Phase 3 | Status: COMPLETED | Results posted: 2019-09-06